Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease

[1]  Ji-Young Lee,et al.  Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[2]  Mark S. Schmidt,et al.  Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures , 2019, Cell reports.

[3]  N. Klimova,et al.  Nicotinamide mononucleotide alters mitochondrial dynamics by SIRT3‐dependent mechanism in male mice , 2019, Journal of neuroscience research.

[4]  R. Tian,et al.  Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease , 2019, Scientific Reports.

[5]  D. Orlicky,et al.  Quantifying Competition among Mitochondrial Protein Acylation Events Induced by Ethanol Metabolism. , 2019, Journal of proteome research.

[6]  N. Selvamurugan,et al.  Role of activating transcription factor 3 and its interacting proteins under physiological and pathological conditions. , 2018, International journal of biological macromolecules.

[7]  J. Baur,et al.  Nicotinamide mononucleotide preserves mitochondrial function and increases survival in hemorrhagic shock. , 2018, JCI insight.

[8]  W. Ling,et al.  Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1/PGC-1α/mitochondrial biosynthesis pathway , 2018, Redox biology.

[9]  J. Loscalzo,et al.  NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism. , 2018, Antioxidants & redox signaling.

[10]  D. Sinclair,et al.  Nicotinamide mononucleotide (NMN) supplementation ameliorates the impact of maternal obesity in mice: comparison with exercise , 2017, Scientific Reports.

[11]  Chen Li,et al.  Hepatoprotective effects of Methyl ferulic acid on alcohol-induced liver oxidative injury in mice by inhibiting the NOX4/ROS-MAPK pathway. , 2017, Biochemical and biophysical research communications.

[12]  Wei Yang,et al.  Resveratrol attenuates excessive ethanol exposure induced insulin resistance in rats via improving NAD+ /NADH ratio. , 2017, Molecular nutrition & food research.

[13]  Young Ho Suh,et al.  Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis. , 2017, Journal of hepatology.

[14]  J. Locasale,et al.  Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy model. , 2017, JCI insight.

[15]  J. Gilley,et al.  NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo , 2017, Current Biology.

[16]  J. Auwerx,et al.  PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis. , 2017, Journal of hepatology.

[17]  U. Matulonis,et al.  PARP inhibitors in ovarian cancer: evidence, experience and clinical potential , 2017, Therapeutic advances in medical oncology.

[18]  S. Imai,et al.  Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice. , 2016, Cell metabolism.

[19]  D. Sinclair,et al.  Head to Head Comparison of Short-Term Treatment with the NAD+ Precursor Nicotinamide Mononucleotide (NMN) and 6 Weeks of Exercise in Obese Female Mice , 2016, Front. Pharmacol..

[20]  Nathan R. Qi,et al.  NAMPT-Mediated NAD(+) Biosynthesis in Adipocytes Regulates Adipose Tissue Function and Multi-organ Insulin Sensitivity in Mice. , 2016, Cell reports.

[21]  S. Srivastava.  Emerging therapeutic roles for NAD+ metabolism in mitochondrial and age-related disorders , 2016, Clinical and Translational Medicine.

[22]  J. Molkentin,et al.  DUSP8 Regulates Cardiac Ventricular Remodeling by Altering ERK1/2 Signaling. , 2016, Circulation research.

[23]  J. Auwerx,et al.  NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. , 2015, Cell metabolism.

[24]  James R. Roede,et al.  Chronic ethanol consumption induces mitochondrial protein acetylation and oxidative stress in the kidney , 2015, Redox biology.

[25]  H. Fallahi,et al.  Predicting transcription factors in human alcoholic hepatitis from gene regulatory network. , 2015, European review for medical and pharmacological sciences.

[26]  J. Locasale,et al.  High-Resolution Metabolomics with Acyl-CoA Profiling Reveals Widespread Remodeling in Response to Diet* , 2015, Molecular & Cellular Proteomics.

[27]  Tim Sonntag,et al.  ATF3 mediates inhibitory effects of ethanol on hepatic gluconeogenesis , 2015, Proceedings of the National Academy of Sciences.

[28]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[29]  M. Zern,et al.  Ethanol Negatively Regulates Hepatic Differentiation of hESC by Inhibition of the MAPK/ERK Signaling Pathway In Vitro , 2014, PloS one.

[30]  A. Colell,et al.  Mitochondrial cholesterol accumulation in alcoholic liver disease: Role of ASMase and endoplasmic reticulum stress , 2014, Redox biology.

[31]  M. Go,et al.  Chronic Ethanol Consumption Inhibits Glucokinase Transcriptional Activity by Atf3 and Triggers Metabolic Syndrome in Vivo , 2014, The Journal of Biological Chemistry.

[32]  Jason W Locasale,et al.  Development and Quantitative Evaluation of a High-Resolution Metabolomics Technology , 2014, Analytical chemistry.

[33]  E. Mercken,et al.  Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging , 2013, Cell.

[34]  Liang Liu,et al.  Carbon monoxide alleviates ethanol-induced oxidative damage and inflammatory stress through activating p38 MAPK pathway. , 2013, Toxicology and applied pharmacology.

[35]  J. Sastre,et al.  p38 MAPK: A dual role in hepatocyte proliferation through reactive oxygen species , 2013, Free radical research.

[36]  R. Roskoski.  ERK1/2 MAP kinases: structure, function, and regulation. , 2012, Pharmacological research.

[37]  J. Auwerx,et al.  The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. , 2012, Cell metabolism.

[38]  S. Imai,et al.  Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. , 2011, Cell metabolism.

[39]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[40]  James R. Roede,et al.  4-Hydroxynonenal inhibits SIRT3 via thiol-specific modification. , 2011, Chemical research in toxicology.

[41]  Marcel Martin.  Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[42]  J. Auwerx,et al.  PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. , 2011, Cell metabolism.

[43]  Etienne Blanc,et al.  ATF4 and the integrated stress response are induced by ethanol and cytochrome P450 2E1 in human hepatocytes. , 2011, Journal of hepatology.

[44]  L. Hui,et al.  Mitogen-activated protein kinases in hepatocellular carcinoma development. , 2011, Seminars in cancer biology.

[45]  M. Gyamfi,et al.  Pathogenesis of alcoholic liver disease: the role of nuclear receptors , 2010, Experimental biology and medicine.

[46]  Zhenyuan Song,et al.  Chronic alcohol consumption disrupted cholesterol homeostasis in rats: down-regulation of low-density lipoprotein receptor and enhancement of cholesterol biosynthesis pathway in the liver. , 2010, Alcoholism, clinical and experimental research.

[47]  P. Garnier,et al.  NAD+ Depletion Is Necessary and Sufficient forPoly(ADP-Ribose) Polymerase-1-Mediated Neuronal Death , 2010, The Journal of Neuroscience.

[48]  P. Mandrekar,et al.  Signalling pathways in alcohol-induced liver inflammation. , 2009, Journal of hepatology.

[49]  P. Tuma,et al.  Alcohol-induced protein hyperacetylation: mechanisms and consequences. , 2009, World journal of gastroenterology.

[50]  V. Purohit,et al.  Molecular mechanisms of alcoholic fatty liver. , 2009, Alcoholism: Clinical and Experimental Research.

[51]  James R. Roede,et al.  Decreased expression of peroxiredoxin 6 in a mouse model of ethanol consumption. , 2008, Free radical biology & medicine.

[52]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[53]  D. Petersen,et al.  Ethanol-induced Modulation of Hepatocellular Extracellular Signal-regulated Kinase-1/2 Activity via 4-Hydroxynonenal* , 2007, Journal of Biological Chemistry.

[54]  T. White,et al.  Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38. , 2006, Biochemical and biophysical research communications.

[55]  S. Milani,et al.  Acetaldehyde Inhibits PPARγ via H2O2-Mediated c-Abl Activation in Human Hepatic Stellate Cells , 2006 .

[56]  P. Dent,et al.  Ethanol reduces p38 kinase activation and cyclin D1 protein expression after partial hepatectomy in rats. , 2006, Journal of hepatology.

[57]  A. Fornace,et al.  The autoimmune suppressor Gadd45α inhibits the T cell alternative p38 activation pathway , 2005, Nature Immunology.

[58]  S. Shukla,et al.  MAP kinase signaling in diverse effects of ethanol. , 2004, Life sciences.

[59]  Robert A Edwards,et al.  Visible fluorescent detection of proteins in polyacrylamide gels without staining. , 2004, Analytical biochemistry.

[60]  J. Fernandez-Checa.  Alcohol-induced liver disease: when fat and oxidative stress meet. , 2003, Annals of hepatology.

[61]  J. Hoek,et al.  Alcohol and mitochondria: a dysfunctional relationship. , 2002, Gastroenterology.

[62]  Tsonwin Hai,et al.  The Roles of ATF3 in Liver Dysfunction and the Regulation of Phosphoenolpyruvate Carboxykinase Gene Expression* , 2002, The Journal of Biological Chemistry.

[63]  J. Chen,et al.  Effects of ethanol on mitogen-activated protein kinase and stress-activated protein kinase cascades in normal and regenerating liver. , 1998, The Biochemical journal.

[64]  C. Wolfgang,et al.  Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10 , 1996, Molecular and cellular biology.

[65]  R. Taub,et al.  Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration. , 1993, The Journal of clinical investigation.

[66]  P. Seifert,et al.  Alcohol Metabolism , 2020, Where Does All That Food Go?.

[67]  A. Cederbaum.  Alcohol Metabolism , 2020, Encyclopedia of Gastroenterology.

[68]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[69]  S. Milani,et al.  Acetaldehyde inhibits PPARgamma via H2O2-mediated c-Abl activation in human hepatic stellate cells. , 2006, Gastroenterology.

[70]  Tsonwin Hai,et al.  ATF3 and stress responses. , 1999, Gene expression.

[71]  C. Lieber.  Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases. , 1997, Advances in pharmacology.

[72]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .